Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1962 1
1963 1
1968 1
1969 1
1970 2
1971 1
1972 3
1973 1
1976 1
1977 7
1978 7
1979 4
1980 15
1981 15
1982 4
1983 11
1984 5
1985 8
1986 2
1987 10
1988 5
1989 7
1990 9
1991 3
1992 6
1993 11
1994 9
1995 7
1996 8
1997 17
1998 6
1999 12
2000 10
2001 18
2002 12
2003 12
2004 21
2005 16
2006 26
2007 24
2008 34
2009 44
2010 36
2011 38
2012 44
2013 53
2014 59
2015 64
2016 70
2017 69
2018 68
2019 74
2020 89
2021 102
2022 96
2023 92
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

1,229 results

Results by year

Citations

7 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.
Klemm F, Maas RR, Bowman RL, Kornete M, Soukup K, Nassiri S, Brouland JP, Iacobuzio-Donahue CA, Brennan C, Tabar V, Gutin PH, Daniel RT, Hegi ME, Joyce JA. Klemm F, et al. Cell. 2020 Jun 25;181(7):1643-1660.e17. doi: 10.1016/j.cell.2020.05.007. Epub 2020 May 28. Cell. 2020. PMID: 32470396 Free PMC article.
Brain malignancies encompass a range of primary and metastatic cancers, including low-grade and high-grade gliomas and brain metastases (BrMs) originating from diverse extracranial tumors. ...We therefore comprehensively analyzed the brain TME landscape via f
Brain malignancies encompass a range of primary and metastatic cancers, including low-grade and high-grade gliomas and brain m
Nutrition and the ageing brain: Moving towards clinical applications.
Flanagan E, Lamport D, Brennan L, Burnet P, Calabrese V, Cunnane SC, de Wilde MC, Dye L, Farrimond JA, Emerson Lombardo N, Hartmann T, Hartung T, Kalliomäki M, Kuhnle GG, La Fata G, Sala-Vila A, Samieri C, Smith AD, Spencer JPE, Thuret S, Tuohy K, Turroni S, Vanden Berghe W, Verkuijl M, Verzijden K, Yannakoulia M, Geurts L, Vauzour D. Flanagan E, et al. Ageing Res Rev. 2020 Sep;62:101079. doi: 10.1016/j.arr.2020.101079. Epub 2020 May 24. Ageing Res Rev. 2020. PMID: 32461136 Free article. Review.
The emergence of new avenues for exploring the role of diet in healthy ageing, such as the impact of the gut microbiome and development of new techniques (imaging measures of brain metabolism, metabolomics, biomarkers) are enabling researchers to approach finding answers t …
The emergence of new avenues for exploring the role of diet in healthy ageing, such as the impact of the gut microbiome and development of n …
A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guideline.
Shemie SD, Wilson LC, Hornby L, Basmaji J, Baker AJ, Bensimon CM, Chandler JA, Chassé M, Dawson R, Dhanani S, Mooney OT, Sarti AJ, Simpson C, Teitelbaum J, Torrance S, Boyd JG, Brennan J, Brewster H, Carignan R, Dawe KJ, Doig CJ, Elliott-Pohl K, Gofton TE, Hartwick M, Healey A, Honarmand K, Hornby K, Isac G, Kanji A, Kawchuk J, Klowak JA, Kramer AH, Kromm J, LeBlanc AE, Lee-Ameduri K, Lee LA, Leeies M, Lewis A, Manara A, Matheson S, McKinnon NKA, Murphy N, Briard JN, Pope TM, Sekhon MS, Shanker JJS, Singh G, Singh J, Slessarev M, Soliman K, Sutherland S, Weiss MJ, Shaul RZ, Zuckier LS, Zorko DJ, Rochwerg B. Shemie SD, et al. Can J Anaesth. 2023 Apr;70(4):483-557. doi: 10.1007/s12630-023-02431-4. Epub 2023 May 2. Can J Anaesth. 2023. PMID: 37131020 Free PMC article.
This 2023 Clinical Practice Guideline provides the biomedical definition of death based on permanent cessation of brain function that applies to all persons, as well as recommendations for death determination by circulatory criteria for potential organ donors and death det …
This 2023 Clinical Practice Guideline provides the biomedical definition of death based on permanent cessation of brain function that …
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A. Sevigny J, et al. Nature. 2016 Sep 1;537(7618):50-6. doi: 10.1038/nature19323. Nature. 2016. PMID: 27582220 Updated.
Alzheimer's disease (AD) is characterized by deposition of amyloid-beta (Abeta) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction and neurodegeneration. ...In a transgenic mouse model of AD, aducanumab is shown to enter the brain, …
Alzheimer's disease (AD) is characterized by deposition of amyloid-beta (Abeta) plaques and neurofibrillary tangles in the brain, acc …
Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.
Greene C, Connolly R, Brennan D, Laffan A, O'Keeffe E, Zaporojan L, O'Callaghan J, Thomson B, Connolly E, Argue R, Meaney JFM, Martin-Loeches I, Long A, Cheallaigh CN, Conlon N, Doherty CP, Campbell M. Greene C, et al. Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Nat Neurosci. 2024. PMID: 38388736 Free PMC article.
Using dynamic contrast-enhanced magnetic resonance imaging, we show BBB disruption in patients with long COVID-associated brain fog. Transcriptomic analysis of peripheral blood mononuclear cells revealed dysregulation of the coagulation system and a dampened adaptive immun …
Using dynamic contrast-enhanced magnetic resonance imaging, we show BBB disruption in patients with long COVID-associated brain fog. …
The origin of brain malignancies at the blood-brain barrier.
McDonald B, Barth K, Schmidt MHH. McDonald B, et al. Cell Mol Life Sci. 2023 Sep 9;80(10):282. doi: 10.1007/s00018-023-04934-1. Cell Mol Life Sci. 2023. PMID: 37688612 Free PMC article. Review.
In this review, we focus on core contributions of the blood-brain barrier to the origin of brain metastases. We first provide an overview of the structure and function of the blood-brain barrier under physiological conditions. ...We then consider the neurotro …
In this review, we focus on core contributions of the blood-brain barrier to the origin of brain metastases. We first provide …
Permeability of the Blood-Brain Barrier after Traumatic Brain Injury: Radiological Considerations.
Amoo M, O'Halloran PJ, Henry J, Ben Husien M, Brennan P, Campbell M, Caird J, Curley GF. Amoo M, et al. J Neurotrauma. 2022 Jan;39(1-2):20-34. doi: 10.1089/neu.2020.7545. Epub 2021 Apr 12. J Neurotrauma. 2022. PMID: 33632026 Review.
Traumatic brain injury (TBI) is a leading cause of death and disability, especially in young persons, and constitutes a major socioeconomic burden worldwide. ...Most of the mechanisms underpinning the development of secondary brain injury are consequences of disrupt …
Traumatic brain injury (TBI) is a leading cause of death and disability, especially in young persons, and constitutes a major socioec …
Somitogenesis.
Brennan C, Amacher SL, Currie PD. Brennan C, et al. Results Probl Cell Differ. 2002;40:271-97. doi: 10.1007/978-3-540-46041-1_14. Results Probl Cell Differ. 2002. PMID: 12353481 Review. No abstract available.
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders.
Writing Committee for the Attention-Deficit/Hyperactivity Disorder; Autism Spectrum Disorder; Bipolar Disorder; Major Depressive Disorder; Obsessive-Compulsive Disorder; and Schizophrenia ENIGMA Working Groups; Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abé C, Anticevic A, Alda M, Aleman A, Alloza C, Alonso-Lana S, Ameis SH, Anagnostou E, McIntosh AA, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Ayesa-Arriola R, Bakker G, Banaj N, Banaschewski T, Bandeira CE, Baranov A, Bargalló N, Bau CHD, Baumeister S, Baune BT, Bellgrove MA, Benedetti F, Bertolino A, Boedhoe PSW, Boks M, Bollettini I, Del Mar Bonnin C, Borgers T, Borgwardt S, Brandeis D, Brennan BP, Bruggemann JM, Bülow R, Busatto GF, Calderoni S, Calhoun VD, Calvo R, Canales-Rodríguez EJ, Cannon DM, Carr VJ, Cascella N, Cercignani M, Chaim-Avancini TM, Christakou A, Coghill D, Conzelmann A, Crespo-Facorro B, Cubillo AI, Cullen KR, Cupertino RB, Daly E, Dannlowski U, Davey CG, Denys D, Deruelle C, Di Giorgio A, Dickie EW, Dima D, Dohm K, Ehrlich S, Ely BA, Erwin-Grabner T, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Fatjó-Vilas M, Fedor JM, Fitzgerald KD, Ford JM, Frodl T, Fu CHY,… See abstract for full author list ➔ Writing Committee for the Attention-Deficit/Hyperactivity Disorder, et al. JAMA Psychiatry. 2021 Jan 1;78(1):47-63. doi: 10.1001/jamapsychiatry.2020.2694. JAMA Psychiatry. 2021. PMID: 32857118 Free PMC article.
1,229 results